Table 3.
Participants with breast abnormalities (n=1995) |
Participants with cervical abnormalities (n=1194) |
|||
---|---|---|---|---|
Barrier Group | Frequency n (%) |
Hazard Ratio (95% CI) |
Frequency n (%) |
Hazard Ratio (95% CI) |
Any Barrier | 1,270 (63.7) | 0.74** (0.67–0.83) | 556 (46.6) | 0.79** (0.70–0.90) |
Patient-Focused | 827 (41.5) | 0.81** (0.72–0.91) | 352 (29.5) | 0.78** (0.68–0.90) |
Other-Focused | 616 (30.9) | 0.98 (0.87–1.09) | 157 (13.1) | 0.78** (0.65–0.94) |
System | 856 (42.9) | 0.78** (0.70–0.87) | 260 (21.8) | 0.82* (0.70–0.95) |
p<0.05;
p<0.01 (significant findings in bold font)
Adjusted HRs estimated from multivariable Cox model stratified by study site with covariates age, race/ethnicity, marital status, and health insurance.